A major new trial has begun in the UK of a treatment that aims to stop COVID patients developing severe illness.
Early results suggest it could cut the chances of infected patients going on to be seriously ill by almost 80 percent.
John Bevir (Beaver) reports.
IN: 'Interferon beta..'
OUT: SOC
DUR: 0:42
http://www.fsnradionews.com/feeds/0113-interferon-bevir-generic.mp3